This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for Trazimera® (trastuzumab)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

  • Trazimera (trastuzumab) 150mg Powder for Concentrate for Solution for Infusion - PI for UK
  • Trazimera (trastuzumab) 420mg Powder for Concentrate for Solution for Infusion - PI for UK

Trazimera (trastuzumab) 150mg Powder for Concentrate for Solution for Infusion - PI for UK

Trazimera (trastuzumab) 420mg Powder for Concentrate for Solution for Infusion - PI for UK

PP-TAS-GBR-0064 January 2025